Recurrence of pseudomyxoma peritonei after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
BJS Open2018Vol. 3(2), pp. 195–202
Citations Over TimeTop 10% of 2018 papers
Frédéric Mercier, François Dagbert, Marc Pocard, Diane Goèré, F. Quénet, Romuald Wernert, F. Dumont, Cécile Brigand, Guillaume Passot, Olivier Gléhen, the RENAPE Network, J. Abba, K. Abboud, Mohammad Alyami, C. Arvieux, Gerlinde Avérous, N. Bakrin, G Balagué, Vincent Barrau, Houda Ben Rejeb, Jean-Marc Béréder, I. Berton Rigaud, Frédéric Bibeau, Isabelle Bonnefoy, D. Bouzard, Ivan Bricault, Caroline Caramella, Sébastien Carrère, Cécile de Chaisemartin, Madleen Chassang, A Chevallier, Thomas Courvoisier, Peggy Dartigues, Anthony Dohan, Clarisse Eveno, Marie Faruch, Gwénaël Ferron, J. Fontaine, Pierre‐Edouard Fournier, Erwan Gabiache, Johan Gagnière, D. Geffroy, Laurent Ghouti, F.N. Gilly, Laurence Gladieff, Aymeric Guibal, Jean‐Marc Guilloit, Frédéric Guyon, Bruno Heyd, Christine Hoeffel, Constance Hordonneau, S. Isaac, Peggy Jourdan Enfer, Rachid Kaci, Réza Kianmanesh, C. Devilliers, Joëlle Lacroix, Bernard Lelong, Amaury Broussier, Yoann Lherm, Réa Lo Dico, G. Lorimier, Caroline Malhaire, François Marchal, Pascale Mariani, E. Mathiotte, Pierre Méeus, Eliane Mery-Lamarche, Simon Msika, C. Nadeau, Stéphanie Nougaret, Pablo Ortega‐Deballon, Brice Paquette, Olivier Pellet, Patrice Peyrat, Denis Pezet, N. Pirró, M. Pocard, Flora Poizat, J. Porcheron, Patrick Rat, Pierre Rousselot, Pascal Rousset, Hélène Senellart, María José Serrano, Vincent Servois, Olivia Sgarbură, Andrea Skanjeti, Magali Svrcek, R. Tétreau, Emilie Thibaudeau, Yann Touchefeu, Jean‐Jacques Tuech, Séverine Valmary Degano, D. Vaudoyer, Stéphane Velasco, V. Verriele Beurrier, Laurent Villeneuve, Franck Zinzindohoué
Abstract
Recurrence of PMP was rare after 5 years and exceptional after 10 years.
Related Papers
- → Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy as a Curative Approach to Pseudomyxoma Peritonei Syndrome(2001)47 cited
- → Outcomes following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal malignancies: 10 Year experience(2024)5 cited
- → Cytoreductive surgery alone or combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for pseudomyxoma peritonei(2018)2 cited
- → 02 / Postoperative outcomes of cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC)(2018)
- → Pseudomyxoma peritonei (PMP): An update on Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal chemotherapy (HIPEC).(2020)